> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Meeting on User Fee Financial Transparency
- URL: https://www.fdaweb.com/meeting-on-user-fee-financial-transparency/
- Published: 2022-05-12T12:00:00.000Z
- Updated: 2026-09-14T17:44:26.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151802

*Federal Register* notice: FDA is announcing a 6/7 public meeting entitled “Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments.” The meeting will include presentations from FDA on topics related to the financial management of certain user fee programs, including presentations on the agency’s five-year financial plan for the user fee programs. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-05-12/pdf/2022-10131.pdf?ref=fdaweb.com).